Microbiology Readers
Chembio Diagnostic Systems, Inc. DPP Micro Reader
The objective results reduce the possibility of the types of human error that can be experienced with visual interpretations.
3M™ Microbial Luminescence System Microwell Plate 3007, Sold by AquaPhoenix Scientific
For use with 3M™ Microbial Luminescence System (MLS)
3M™ Microbial Luminescence System Microwell Strip 3008, Sold by AquaPhoenix Scientific
For use with 3M™ Microbial Luminescence System (MLS)
3M™ Microbial Luminescence System MLSII, Sold by AquaPhoenix Scientific
Uses ATP bioluminescence in microwell based system to detect microbial ATP in Ultra Heat Treated (UTH) and Extended Shelf Life (ESL) dairy and dairy end products
Revvity Health Sciences Inc Universal Microbial Homogenizing Mix 0.1 mm Ceramic (2 mL Tubes) (1000/pk)
Universal Microbial Homogenizing Mix 0.1 mm Ceramic (2 mL Tubes) (1000/pk)
Revvity Health Sciences Inc Universal Microbial Homogenizing Mix 0.1 mm Ceramic (2 mL Tubes) - Microbial DNA Free (1000/pk)
Universal Microbial Homogenizing Mix 0.1 mm Ceramic (2 mL Tubes) - Microbial DNA Free (1000/pk)
Cayman Chemical DPP-9 InhIbItr 42 1mg
A DPP-9 inhibitor (IC50 = 0.0034 µM); selective for DDP-9 over DPP-8, DPP-4, DPP-2, FAP, and prolyl endopeptidase (IC50s = 0.6, >10, >5, 10, and >10 µM, respectively); induces LDH release from THP-1 and HL-60 leukemia cells at 10 µM
Cayman Chemical DPP-9 InhIbItr 42 10mg
A DPP-9 inhibitor (IC50 = 0.0034 µM); selective for DDP-9 over DPP-8, DPP-4, DPP-2, FAP, and prolyl endopeptidase (IC50s = 0.6, >10, >5, 10, and >10 µM, respectively); induces LDH release from THP-1 and HL-60 leukemia cells at 10 µM
Cayman Chemical DPP-9 InhIbItr 42 50mg
A DPP-9 inhibitor (IC50 = 0.0034 µM); selective for DDP-9 over DPP-8, DPP-4, DPP-2, FAP, and prolyl endopeptidase (IC50s = 0.6, >10, >5, 10, and >10 µM, respectively); induces LDH release from THP-1 and HL-60 leukemia cells at 10 µM
Abcam NVP DPP 728, DPP-IV inhibitor, 5MG
MW 371.3 Da, Purity >98%. Potent, selective, reversible dipeptidyl peptidase-IV (DPP-IV) inhibitor (Ki = 11 nM). Antidiabetic agent in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
- 1
- 2